Longitudinal analysis of the in vitro activity profile of oritavancin and comparator glycopeptides against Gram-positive organisms from Europe: 2005-2008

被引：10

作者：

Arhin, Francis F. ^{[1
]}

Moeck, Gregory ^{[1
]}

Draghi, Deborah C. ^{[2
]}

Pillar, Chris M. ^{[2
]}

Sahm, Daniel F. ^{[2
]}

机构：

[1] Medicines Co, St Laurent, PQ H4S 2A1, Canada

[2] Eurofins Medinet, Chantilly, VA 20151 USA

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2010年 / 36卷 / 05期

关键词：

D O I：

10.1016/j.ijantimicag.2010.07.010

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：474 / 476

页数：3

共 6 条

[1]

Allen Norris E., 2010, Anti-Infective Agents in Medicinal Chemistry, V9, P23

[2]

[Anonymous], 2009, M100S19 CLIN LAB STA

[3] Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates [J].

Arhin, Francis F. ;

Draghi, Deborah C. ;

Pillar, Chris M. ;

Parr, Thomas R., Jr. ;

Moeck, Gregory ;

Sahm, Daniel F. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) :4762-4771

[4]

CLINICAL LABORATORY STANDARDS INSTITUTE, 2009, M7A8 CLSI

[5] Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium [J].

McKay, Geoffrey A. ;

Beaulieu, Sylvain ;

Arhin, Francis F. ;

Belley, Adam ;

Sarmiento, Ingrid ;

Parr, Thomas, Jr. ;

Moeck, Gregory .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) :1191-1199

[6] Management of multidrug-resistant organisms in health care settings, 2006 [J].

Siegel, Jane D. ;

Rhinehart, Emily ;

Jackson, Marguerite ;

Chiarello, Linda .

AMERICAN JOURNAL OF INFECTION CONTROL, 2007, 35 (10) :S165-S193

← 1 →